Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Epicatechin

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Epicatechin?

Epicatechin is an investigational drug.

There have been 13 clinical trials for Epicatechin. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2007.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Prediabetic State. The leading clinical trial sponsors are Cardero Therapeutics, Inc., National Center for Complementary and Integrative Health (NCCIH), and Craig McDonald, MD.

Recent Clinical Trials for Epicatechin
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory AdolescentsCardero Therapeutics, Inc.Phase 1/Phase 2
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory AdolescentsCraig McDonald, MDPhase 1/Phase 2
(-)- Epicatechin Becker Muscular DystrophyCardero Therapeutics, Inc.Phase 2

See all Epicatechin clinical trials

Clinical Trial Summary for Epicatechin

Top disease conditions for Epicatechin
Top clinical trial sponsors for Epicatechin

See all Epicatechin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.